HIMS & HERS HEALTH INC (HIMS) Fundamental Analysis & Valuation

NYSE:HIMS • US4330001060

Current stock price

19.35 USD
-0.4 (-2.03%)
Last:

This HIMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HIMS Profitability Analysis

1.1 Basic Checks

  • In the past year HIMS was profitable.
  • HIMS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: HIMS reported negative net income in multiple years.
  • In multiple years HIMS reported negative operating cash flow during the last 5 years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • HIMS has a Return On Assets of 5.96%. This is in the better half of the industry: HIMS outperforms 79.00% of its industry peers.
  • HIMS's Return On Equity of 23.73% is amongst the best of the industry. HIMS outperforms 91.00% of its industry peers.
  • HIMS has a Return On Invested Capital of 5.49%. This is comparable to the rest of the industry: HIMS outperforms 59.00% of its industry peers.
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROIC 5.49%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • The Profit Margin of HIMS (5.47%) is better than 79.00% of its industry peers.
  • HIMS has a better Operating Margin (5.18%) than 62.00% of its industry peers.
  • HIMS's Gross Margin of 73.83% is amongst the best of the industry. HIMS outperforms 90.00% of its industry peers.
  • In the last couple of years the Gross Margin of HIMS has declined.
Industry RankSector Rank
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. HIMS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
  • HIMS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for HIMS has been increased compared to 5 years ago.
  • HIMS has a worse debt/assets ratio than last year.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 3.08 indicates that HIMS is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.08, HIMS is doing good in the industry, outperforming 68.00% of the companies in the same industry.
  • The Debt to FCF ratio of HIMS is 16.94, which is on the high side as it means it would take HIMS, 16.94 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 16.94, HIMS is doing worse than 63.00% of the companies in the same industry.
  • A Debt/Equity ratio of 1.80 is on the high side and indicates that HIMS has dependencies on debt financing.
  • HIMS has a Debt to Equity ratio of 1.80. This is in the lower half of the industry: HIMS underperforms 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Altman-Z 3.08
ROIC/WACC0.64
WACC8.53%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • HIMS has a Current Ratio of 1.90. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • HIMS has a Current ratio of 1.90. This is in the better half of the industry: HIMS outperforms 80.00% of its industry peers.
  • HIMS has a Quick Ratio of 1.70. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • HIMS has a Quick ratio of 1.70. This is in the better half of the industry: HIMS outperforms 73.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.7
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. HIMS Growth Analysis

3.1 Past

  • The earnings per share for HIMS have decreased by -5.56% in the last year.
  • The Revenue has grown by 59.00% in the past year. This is a very strong growth!
  • HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 64.55% yearly.
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%

3.2 Future

  • HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 50.73% yearly.
  • HIMS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.53% yearly.
EPS Next Y7.08%
EPS Next 2Y17.86%
EPS Next 3Y29.51%
EPS Next 5Y50.73%
Revenue Next Year17.57%
Revenue Next 2Y18.39%
Revenue Next 3Y17.66%
Revenue Next 5Y14.53%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. HIMS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 37.94, HIMS can be considered very expensive at the moment.
  • HIMS's Price/Earnings is on the same level as the industry average.
  • HIMS is valuated rather expensively when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 35.43, which means the current valuation is very expensive for HIMS.
  • The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
  • HIMS is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 37.94
Fwd PE 35.43
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • HIMS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, HIMS is valued a bit more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 76.82
EV/EBITDA 25.81
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • HIMS's earnings are expected to grow with 29.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.36
PEG (5Y)N/A
EPS Next 2Y17.86%
EPS Next 3Y29.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIMS Dividend Analysis

5.1 Amount

  • HIMS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIMS Fundamentals: All Metrics, Ratios and Statistics

HIMS & HERS HEALTH INC

NYSE:HIMS (4/10/2026, 3:41:09 PM)

19.35

-0.4 (-2.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners85.66%
Inst Owner Change0%
Ins Owners6.6%
Ins Owner Change21.93%
Market Cap4.41B
Revenue(TTM)2.35B
Net Income(TTM)128.37M
Analysts70
Price Target25.63 (32.45%)
Short Float %40.55%
Short Ratio2.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.8%
Min EPS beat(2)-43.53%
Max EPS beat(2)71.14%
EPS beat(4)3
Avg EPS beat(4)25.02%
Min EPS beat(4)-43.53%
Max EPS beat(4)71.14%
EPS beat(8)7
Avg EPS beat(8)139.72%
EPS beat(12)10
Avg EPS beat(12)110.2%
EPS beat(16)13
Avg EPS beat(16)84.74%
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)1.2%
Revenue beat(4)2
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.24%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)12
Avg Revenue beat(16)2.47%
PT rev (1m)-14.58%
PT rev (3m)-44.76%
EPS NQ rev (1m)-58.13%
EPS NQ rev (3m)-79.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.87%
Revenue NQ rev (1m)-0.53%
Revenue NQ rev (3m)-5.81%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 37.94
Fwd PE 35.43
P/S 1.88
P/FCF 76.82
P/OCF 14.7
P/B 8.15
P/tB 66.34
EV/EBITDA 25.81
EPS(TTM)0.51
EY2.64%
EPS(NY)0.55
Fwd EY2.82%
FCF(TTM)0.25
FCFY1.3%
OCF(TTM)1.32
OCFY6.8%
SpS10.3
BVpS2.37
TBVpS0.29
PEG (NY)5.36
PEG (5Y)N/A
Graham Number5.22
Profitability
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROCE 6.95%
ROIC 5.49%
ROICexc 8.2%
ROICexgc 13.77%
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
FCFM 2.45%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
F-Score5
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Debt/EBITDA 5.52
Cap/Depr 445.11%
Cap/Sales 10.33%
Interest Coverage 250
Cash Conversion 170.27%
Profit Quality 44.73%
Current Ratio 1.9
Quick Ratio 1.7
Altman-Z 3.08
F-Score5
WACC8.53%
ROIC/WACC0.64
Cap/Depr(3y)344.08%
Cap/Depr(5y)250.41%
Cap/Sales(3y)5.65%
Cap/Sales(5y)4.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
EPS Next Y7.08%
EPS Next 2Y17.86%
EPS Next 3Y29.51%
EPS Next 5Y50.73%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year17.57%
Revenue Next 2Y18.39%
Revenue Next 3Y17.66%
Revenue Next 5Y14.53%
EBIT growth 1Y78.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year197.78%
EBIT Next 3Y70.33%
EBIT Next 5Y47.66%
FCF growth 1Y-71.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.48%
OCF growth 3YN/A
OCF growth 5YN/A

HIMS & HERS HEALTH INC / HIMS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to HIMS.


What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a valuation rating of 1 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.


How profitable is HIMS & HERS HEALTH INC (HIMS) stock?

HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 4 / 10.


How financially healthy is HIMS & HERS HEALTH INC?

The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.


What is the expected EPS growth for HIMS & HERS HEALTH INC (HIMS) stock?

The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 7.08% in the next year.